ClearPoint Neuro (CLPT) Net Income towards Common Stockholders Growth (3y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -6.51% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 7.96% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -2.19% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 64.73% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 30.89% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 60.12% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 29.56% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | ClearPoint Neuro | 375.84 Mn | 340.24 Mn | 7.76 Mn | -18.70% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -18.70% |
| Dec 31, 2025 | -20.33% |
| Sep 30, 2025 | -15.79% |
| Jun 30, 2025 | -10.77% |
| Mar 31, 2025 | -14.92% |
| Dec 31, 2024 | -9.11% |
| Sep 30, 2024 | -7.16% |
| Jun 30, 2024 | -6.52% |
| Mar 31, 2024 | -18.16% |
| Dec 31, 2023 | -23.99% |
| Sep 30, 2023 | -49.25% |
| Jun 30, 2023 | -62.17% |
| Mar 31, 2023 | -40.69% |
| Dec 31, 2022 | -39.48% |
| Sep 30, 2022 | -50.03% |
| Jun 30, 2022 | -40.39% |
| Mar 31, 2022 | -47.93% |
| Dec 31, 2021 | -50.47% |
| Sep 30, 2021 | -40.64% |
| Jun 30, 2021 | -24.63% |
| Mar 31, 2021 | -14.49% |
| Sep 30, 2019 | 16.76% |
| Jun 30, 2019 | 12.34% |
| Mar 31, 2019 | 18.61% |
| Sep 30, 2018 | 13.45% |
| Jun 30, 2018 | 14.26% |
| Mar 31, 2018 | 19.79% |
| Sep 30, 2016 | 0.59% |
| Jun 30, 2016 | -0.06% |
| Mar 31, 2016 | 5.74% |
| Sep 30, 2015 | -26.94% |
| Jun 30, 2015 | -73.32% |
| Mar 31, 2015 | 2.26% |
| Dec 31, 2014 | -14.82% |
| Sep 30, 2014 | -10.78% |
| Jun 30, 2014 | -6.44% |
| Mar 31, 2014 | 42.75% |